Amylyx Pharmaceuticals, Inc. AMLX Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s income tax?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported income tax of $46K in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s income tax increased by 107.2% year-over-year, from -$635K to $46K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s income tax?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s income tax has grown at a -61.0% compound annual growth rate (CAGR), from $774K to $46K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.